マスター・オブザーバショナル・トライアル: 精密医学を進めるための新しいマスター・プロトコル
Dane Dickson1, Jennifer Johnson2, Raymond Bergan3
1Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA; Taproot Health, Salt Lake City, UT, USA.
Cell
|January 18, 2020
まとめ
新しいマスター観察試験 (MOT) は,分子プロトコルと現実世界のデータを組み合わせています. このアプローチは分子医学を加速し 独特の質問に答え 他の試験と統合することで 精密医学の研究を強化します
科学分野:
- 臨床試験の設計
- 分子医学
- 現実世界のデータ分析
背景:
- 伝統的な臨床試験は 複雑な分子問題に対処する上で 限界に直面しています
- 精密医療の進歩には 多様なデータ源を統合することが不可欠です
研究 の 目的:
- マスター・オブザーバショナル・トライアル (MOT) を新しい臨床試験として導入する.
- MOTは分子プロトコルと 現実世界のデータをハイブリッド化します
- 分子医学と精密医療の進歩におけるMOTの役割を強調する.
主な方法:
- マスター・オブザーバショナル・トライアル (MOT) は概念的な枠組みです.
- 分子ベースのマスター介入プロトコルを統合しています.
- リアルなデータを活用します
主要な成果:
- MOTは 急速な分子医学の進歩のための 臨床的場を提供しています
- 典型的な介入試験では扱われない問題を扱っている.
- 診断と治療の介入試験と 完全に統合できます
結論:
- MOTは,精密医療におけるより包括的なデータ収集エコシステムを促進します.
- このコンストラクタは 分子医学と精密医学の研究の能力を高めています
- これは臨床試験の方法論における 重要な進歩です
関連する概念動画
Clinical Trials: Overview
4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Study Designs in Epidemiology
805
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
805
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
347
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
347
Master Transcription Regulators
7.6K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K


